Literature DB >> 29392299

Validating Fatigue Safety Factor Calculation Methods for Cardiovascular Stents.

.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29392299      PMCID： PMC6352986          DOI： 10.1115/1.4039173

Source DB:  PubMed          Journal:  J Biomech Eng        ISSN： 0148-0731            Impact factor:   2.097


× No keyword cloud information.
  21 in total

1.  One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).

Authors:  Takao Ohki; John F Angle; Hiroyoshi Yokoi; Michael R Jaff; Jeffrey Popma; Guy Piegari; Yuji Kanaoka
Journal:  J Vasc Surg       Date:  2015-10-17       Impact factor: 4.268

2.  Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.

Authors:  Jiro Aoki; Gaku Nakazawa; Kengo Tanabe; Angela Hoye; Hirosada Yamamoto; Tomohiro Nakayama; Yoshinobu Onuma; Yasutomi Higashikuni; Syuji Otsuki; Atsuhiko Yagishita; Sen Yachi; Hiroyoshi Nakajima; Kazuhiro Hara
Journal:  Catheter Cardiovasc Interv       Date:  2007-02-15       Impact factor: 2.692

3.  S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.

Authors:  William A Gray; Andrew Feiring; Marco Cioppi; Robert Hibbard; Bruce Gray; Yazan Khatib; David Jessup; William Bachinsky; Ernesto Rivera; Jeffrey Tauth; Roberto Patarca; Joe Massaro; Hans-Peter Stoll; Michael R Jaff
Journal:  J Vasc Interv Radiol       Date:  2014-11-15       Impact factor: 3.464

4.  Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.

Authors:  H Sarkadi; V Bérczi; A Kollár; D Kiss; P Jakabfi; E M Végh; B Nemes; B Merkely; K Hüttl; E Dósa
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-01-08       Impact factor: 7.069

5.  Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.

Authors:  Stephan H Duda; Benjamin Pusich; Goetz Richter; Peter Landwehr; Vincent L Oliva; Alexander Tielbeek; Benjamin Wiesinger; Jan Bart Hak; Hans Tielemans; Gerhard Ziemer; Ecatarina Cristea; Alexandra Lansky; Jean P Bérégi
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

6.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.

Authors:  Gaku Nakazawa; Aloke V Finn; Marc Vorpahl; Elena Ladich; Robert Kutys; Isidora Balazs; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

7.  Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation.

Authors:  Hisashi Umeda; Tomoko Gochi; Mitsunori Iwase; Hideo Izawa; Takeshi Shimizu; Ryoji Ishiki; Haruo Inagaki; Junji Toyama; Mitsuhiro Yokota; Toyoaki Murohara
Journal:  Int J Cardiol       Date:  2008-03-14       Impact factor: 4.164

8.  A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.

Authors:  Jeffrey J Popma; Klaus Tiroch; Alexandra Almonacid; Sidney Cohen; David E Kandzari; Martin B Leon
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

9.  Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers.

Authors:  Jing Kan; Zhen Ge; Jun-Jie Zhang; Zhi-Zhong Liu; Nai-Liang Tian; Fei Ye; Sui-Ji Li; Xue-Song Qian; Song Yang; Meng-Xuan Chen; Tanveer Rab; Shao-Liang Chen
Journal:  JACC Cardiovasc Interv       Date:  2016-03-18       Impact factor: 11.195

10.  Treatment of TASC C and D Femoropoliteal Lesions with Paclitaxel eluting Stents: 12 month Results of the STELLA-PTX Registry.

Authors:  J M Davaine; J Querat; A Kaladji; B Guyomarch; P Chaillou; A Costargent; T Quillard; Y Gouëffic
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-09-02       Impact factor: 7.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.